UTHR
United Therapeutics Corp
stockNASDAQ
united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of "medicines for life" and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 485.54 | 2026-09-28 | +11.55% | -11.749 |
| 1M | 487.61 | 2026-09-04 | +11.08% | -1.086 |
| 3M | 547.25 | 2026-07-06 | -1.02% | -0.366 |
| 6M | 559.65 | 2026-04-06 | -3.22% | -0.023 |
| 1Y | 453.07 | 2025-10-03 | +19.55% | 0.215 |
| 2Y | 355.93 | 2024-10-04 | +52.18% | — |
| 5Y | 185.37 | 2021-10-04 | +192.19% | 0.394 |
United Therapeutics Corp (NASDAQ:UTHR) stock price today is $541.64, and today's volume is 1,117,875. UTHR is down 5.205% today. The 30 day average volume is 808,303. UTHR market cap is $23.23B with 42.89M shares outstanding.